Althera Pharms Drug Patent Portfolio
Althera Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Althera Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10376470 | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases | 01 May, 2033 | Active |
| US9763885 | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases | 01 May, 2033 | Active |
Latest Legal Activities on Althera Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Althera Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 13 Feb, 2023 | US10376470 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Oct, 2021 | US9763885 |
|
Email Notification
Critical
| 08 Oct, 2021 | US10376470 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Oct, 2021 | US10376470 |
|
Email Notification
Critical
| 08 Oct, 2021 | US9763885 |
|
Correspondence Address Change
Critical
| 06 Oct, 2021 | US10376470 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Nov, 2020 | US9763885 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 13 Aug, 2019 | US10376470 |
|
Recordation of Patent Grant Mailed
Critical
| 13 Aug, 2019 | US10376470 |
|
Email Notification
Critical
| 25 Jul, 2019 | US10376470 |
|
Issue Notification Mailed
Critical
| 24 Jul, 2019 | US10376470 |
| Dispatch to FDC | 03 Jul, 2019 | US10376470 |
| Filing Receipt - Corrected | 26 Jun, 2019 | US10376470 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jun, 2019 | US10376470 |
|
Email Notification
Critical
| 26 Jun, 2019 | US10376470 |
Althera Pharms's Family Patents
Althera Pharms Drug List
Given below is the complete list of Althera Pharms's drugs and the patents protecting them.
1. Roszet
Roszet is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10376470 | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
01 May, 2033
(8 years from now)
| Active |
| US9763885 | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
01 May, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Roszet's drug page